Literature DB >> 11413077

Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement.

A V Alexandrov1, W S Burgin, A M Demchuk, A El-Mitwalli, J C Grotta.   

Abstract

BACKGROUND: Arterial recanalization precedes clinical improvement or may lead to hemorrhage or reperfusion injury. Speed of clot lysis was not previously measured in human stroke. METHODS AND
RESULTS: Transcranial Doppler (TCD) and the National Institutes of Health Stroke Scale (NIHSS) were used to monitor consecutive patients receiving intravenous tissue plasminogen activator (tPA), before tPA bolus and at 24 hours. Patients with complete or partial recanalization of the middle cerebral or basilar artery on TCD were studied. Recanalization was classified a priori as sudden (abrupt appearance of a normal or stenotic low-resistance signal), stepwise (flow improvement over 1 to 29 minutes), or slow (>/=30 minutes). Recanalization was documented in 43 tPA-treated patients (age 68+/-17 years; NIHSS score 16.8+/-6, median 15 points). tPA bolus was given at a mean of 135+/-61 minutes after symptom onset. Recanalization began at a median of 17 minutes and was completed at 35 minutes after tPA bolus, with mean duration of recanalization of 23+/-16 minutes. Recanalization was sudden in 5, stepwise in 23, and slow in 15 patients. Faster recanalization predicted better short-term improvement (P=0.03). At 24 hours, 80%, 30%, and 13% of patients in these respective recanalization groups had NIHSS scores of 0 to 3. Symptomatic hemorrhage occurred in only 1 patient, who had stepwise recanalization 5.5 hours after stroke onset. Slow or partial recanalization with dampened flow signal was found in 53% of patients with total NIHSS scores >10 points at 24 hours (P=0.01). Complete recanalization (n=25) occurred faster (median 10 minutes) than partial recanalization (n=18; median 30 minutes; P=0.0001).
CONCLUSIONS: Rapid arterial recanalization is associated with better short-term improvement, mostly likely because of faster and more complete clot breakup with low resistance of the distal circulatory bed. Slow (>/=30 minutes) flow improvement and dampened flow signal are less favorable prognostic signs. These findings may be evaluated to assist with selection of patients for additional pharmacological or interventional treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11413077     DOI: 10.1161/01.cir.103.24.2897

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  44 in total

1.  Combination treatment with rt-PA is more effective than rt-PA alone in an in vitro human clot model.

Authors:  Jason M Meunier; Christy K Holland; Tyrone M Porter; Christopher J Lindsell; George J Shaw
Journal:  Curr Neurovasc Res       Date:  2011-11       Impact factor: 1.990

Review 2.  Ultrasound- and microspheres-enhanced thrombolysis for stroke treatment: state of the art.

Authors:  Clotilde Balucani; Andrei V Alexandrov
Journal:  Curr Cardiol Rep       Date:  2010-01       Impact factor: 2.931

3.  Lithium treatment reduces brain injury induced by focal ischemia with partial reperfusion and the protective mechanisms dispute the importance of akt activity.

Authors:  Tetsuya Takahashi; Gary K Steinberg; Heng Zhao
Journal:  Aging Dis       Date:  2012-02-08       Impact factor: 6.745

4.  Recurrent artery-to-artery embolism during intravenous t-PA therapy for acute ischemic stroke.

Authors:  Christopher D Anderson; Deborah L Bergman; Richard A Bernstein
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 5.  Mechanical interventions to treat acute stroke.

Authors:  David Fussell; H Christian Schumacher; Philip M Meyers; Randall T Higashida
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

Review 6.  Hyperacute imaging of ischemic stroke: role in therapeutic management.

Authors:  Scott L Selco; David S Liebeskind
Journal:  Curr Cardiol Rep       Date:  2005-01       Impact factor: 2.931

7.  Potentiating intra-arterial sonothrombolysis for acute ischemic stroke by the addition of the ultrasound contrast agents (Optison™ & SonoVue(®)).

Authors:  Azita Soltani; Ruchi Singhal; Melissa Obtera; Ronald A Roy; Wayne M Clark; Douglas R Hansmann
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

8.  Sonothrombolysis: an emerging modality for the treatment of acute ischemic and hemorrhagic stroke.

Authors:  Azita Soltani; Wayne M Clark; Douglas R Hansmann
Journal:  Transl Stroke Res       Date:  2011-04-15       Impact factor: 6.829

9.  The protective effects of T cell deficiency against brain injury are ischemic model-dependent in rats.

Authors:  Xiaoxing Xiong; Lijuan Gu; Hongfei Zhang; Baohui Xu; Shengmei Zhu; Heng Zhao
Journal:  Neurochem Int       Date:  2012-12-08       Impact factor: 3.921

Review 10.  Transcranial Doppler ultrasonography: From methodology to major clinical applications.

Authors:  Antonello D'Andrea; Marianna Conte; Massimo Cavallaro; Raffaella Scarafile; Lucia Riegler; Rosangela Cocchia; Enrica Pezzullo; Andreina Carbone; Francesco Natale; Giuseppe Santoro; Pio Caso; Maria Giovanna Russo; Eduardo Bossone; Raffaele Calabrò
Journal:  World J Cardiol       Date:  2016-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.